Mesa Laboratories, Inc
Price
FilingsNewest: Form 8-K, results of operationsNov 9 →Insiders4 insiders bought $1.4M in 5 open-market buys. 4 insiders sold $1.6M, 3 of 7 sales on a 10b5-1 plan.→HoldersLong Path Partners 8.5%BlackRock 7.8%Boston Partners 4.7%→PeersClosest companies: AZTA, BIO, A→
From the filings
Figures
- Revenue
- $251.3Mlast 12 months
- Net income
- $6.7Mlast 12 months
- Operating cash flow
- $55.7Mlast 12 months
- Cash and equivalents
- $22.3Mat the last balance sheet
- Total debt
- $64.7Mat the last balance sheet
- Shares outstanding
- 5.6M shareson issue
Filings, newest first
- Nov 98-KResults of operations
- Nov 910-QQuarterly report
- Oct 294Insider trade
- Oct 138-KExit or restructuring costs
- Oct 913GStake over 5%, passive
- Sep 114Insider trade
- Sep 88-KShareholder vote
- Aug 1010-QQuarterly report
- Aug 108-KResults of operations
- Jul 308-KCode of ethics change
- Jun 210-KAnnual report